Philips Unveils Breakthrough Imaging Innovations at RSNA 2013

Geschrieben am 01-12-2013

Chicago (ots/PRNewswire) -

Developed in collaboration with leading clinicians, Philips'
Vereos digital PET/CT system and IQon Spectral CT system[1] are
designed to create a short path to the best care and help improve
patient care

At the 99th Annual Meeting of the Radiological Society of North
America (RSNA) in Chicago, Royal Philips today illustrated its
technology leadership in medical imaging with the introduction of two
fundamentally new developments: its Vereos PET/CT [http://www.health
s.html ] fully digital positron emission tomography/computed
tomography (PET/CT) imaging system, and its IQon Spectral CT[1]
spectral detector-based computed tomography (CT) imaging system.

These new innovations further expand Philips' integrated radiology
product portfolio to deliver advanced image quality, critical
information and connectivity for seamless real-time collaboration
among clinicians and fast, confident decision making. Philips
partners with clinicians to drive the clinical performance and
economic value of its solutions to find the shortest path to the best
care with the most efficient use of resources.

"We work closely with radiologists to understand their biggest
challenges, and incorporate these understandings in the development
of innovative products like Vereos PET/CT and IQon Spectral CT to
meet their complex imaging needs," said Gene Saragnese, CEO, Imaging
Systems at Philips Healthcare. "These innovations demonstrate how
Philips is providing radiologists with exceptional quality and
accuracy in imaging at low dose rates, helping clinicians to get
answers, the first time around, so that they can deliver accurate and
more confident diagnoses to patients."

"The timing and precision of disease diagnosis are critical to the
successful treatment of many diseases," commented Pablo Ros, M.D.,
Chairman of the Department of Radiology, University Hospitals Case
Medical Center and Case Western Reserve University, Cleveland, Ohio.
"With that in mind, we are excited to have contributed to the
development of Philips' Vereos digital PET/CT and IQon Spectral CT
systems and we will continue to collaborate with Philips to realize
the potential of these next generation imaging systems."

Vereos PET/CT

PET scans are three-dimensional images that provide insight into
what is happening inside the body at the molecular and cellular
level. A small amount of radiotracer is injected into the patient
prior to the exam, which accumulates in the body's tissue and organs,
and decays. The PET detector captures pairs of photons that are
emitted from the body during this decay process and forms the image.
Based on Philips' proprietary 'Digital Photon Counting' technology,
the Vereos PET/CT [http://www.healthcare.philips.com/us_en/clinicals
pecialities/Radiology/Solutions/vereos.html ] is the first PET/CT
system in the industry to use innovative digital silicon
photomultiplier detectors instead of traditional analog detectors,
resulting in a step change in performance that includes an
approximately two-times increase in sensitivity gain, volumetric
resolution and quantitative accuracy compared to analog systems.[2]
These radical improvements can ultimately be translated into high
image quality, increased diagnostic confidence, improved treatment
planning and faster workflows.

"Personalized medicine will require a patient-specific picture of
the functional processes associated with disease," added Pablo Ros,
M.D. "Accurate quantification of processes is therefore an important
requirement for functional imaging in diagnosis, therapy and
research. The quantitative accuracy and remarkably clear images that
the new digital PET/CT system delivers are a key step forward."

In a recent survey, nine out of ten referring physicians preferred
Vereos digital PET/CT [http://www.healthcare.philips.com/us_en/clini
calspecialities/Radiology/Solutions/vereos.html ] images over images
taken with an analog system.[3] Philips has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) to market
its digital PET/CT system in the U.S.

IQon Spectral CT[1]

Philips' second RSNA introduction - its IQon Spectral CT system -
is the world's first spectral-detector CT system built from the
ground up for spectral imaging. It uses color to identify the
composition of an image without involving time-consuming protocols.
In the same way that white light is made up of a spectrum of colors,
the X-ray beam used in CT scanners also consists of a spectrum of
X-ray energies. With the development of a fundamentally new spectral
detector that can discriminate between X-ray photons of multiple high
and low energies simultaneously, Philips' IQon Spectral CT adds a new
dimension to CT imaging, delivering not only anatomical information
but also the ability to characterize structures based on their
material makeup within a single scan.

After a spectral CT examination, clinicians can interpret the
conventional grey-scale anatomical images, and if necessary, access
the spectral information that was acquired during the same scan. The
IQon Spectral CT system's retrospective on-demand data analysis is
made possible via Philips' iPatient platform, allowing clinicians to
easily experience the benefits of spectral CT routinely within
traditional radiology workflows.

Due to its accessibility, speed and accuracy, CT imaging is widely
used in the diagnosis of many different diseases and injuries,
totaling approximately 450 million imaging procedures globally per
year. Philips has consistently driven innovation in CT, most recently
with the introduction of its proprietary Iterative Model
Reconstruction (IMR) technology to simultaneously reduce CT radiation
dose[4] and enhance image quality for a broad range of applications.

Philips at RSNA 2013 Visit Philips at RSNA 2013 at booth #6733 in
the North Building, Hall B, of the McCormick Place Convention Center
from December 1-6. For additional materials and images of Philips'
IQon Spectral CT[1] and Vereos PET/CT [http://www.healthcare.philips
.com/us_en/clinicalspecialities/Radiology/Solutions/vereos.html ] ,
and for more information on Philips' portfolio of radiology solutions
featured at RSNA 2013, please click on this link [http://www.health
html ] .

[1] The IQon Spectral CT is pending 510(k) and is not available
for sale in the U.S. A system with the NanoPanel Prism detector is
available for sale in the U.S. for conventional scanning.

[2] Analog system: Philips GEMINI TF 16.

[3] Based on a recent survey, commissioned by Philips, among
referring oncologists when shown Philips GEMINI TF 16 images (analog
system) and Philips Vereos PET/CT images (digital system).

[4] In clinical practice, the use of IMR may reduce CT patient
dose depending on the clinical task, patient size, anatomical
location and clinical practice. A consultation with a radiologist and
a physicist should be made to determine the appropriate dose to
obtain diagnostic image quality for the particular clinical task.

About Royal Philips:

Royal Philips is a diversified health and well-being company,
focused on improving people's lives through meaningful innovation in
the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2012 sales of EUR
24.8 billion and employs approximately 114,000 employees with sales
and services in more than 100 countries. The company is a leader in
cardiac care, acute care and home healthcare, energy efficient
lighting solutions and new lighting applications, as well as male
shaving and grooming and oral healthcare. News from Philips is
located at http://www.philips.com/newscenter.

ots Originaltext: Royal Philips
Im Internet recherchierbar: http://www.presseportal.de

For further information, please contact:

Steve Klink
Philips Group Communications
Tel.: +31-6-10888824
E-mail: steve.klink@philips.com

Rachel Bloom-Baglin
Philips Healthcare
Tel.: +1-978-760-9007
E-mail: rachel.bloom-baglin@philips.com

Leslie Lakis
Philips Healthcare
Tel.: +1-978-273-9692
E-mail: leslie.lakis@philips.com


Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.


Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de


weitere Artikel:
  • WAZ: Zeit, die Währung bei Thyssen-Krupp - Kommentar von Thomas Wels Essen (ots) - Besondere Notsituationen führen zuweilen zu besonderen Wortschöpfungen. Bei Thyssen-Krupp haben sie sich das hübsche Wörtchen "Aufräumkosten" einfallen lassen, um dort hineinzupacken, was im abgelaufenen Geschäftsjahr zu einem Verlust von 1,5 Milliarden Euro geführt hat. Eine immer noch monströse Zahl, doch angesichts der fünf Milliarden Minus im Jahr zuvor gilt: Elend ist relativ. Die Vergangenheitsbewältigung ist mühsam. Es wird noch einige Jahre dauern, bis der Konzern das Brasilien-Desaster so weit verdaut mehr...

  • Westfalen-Blatt: Das WESTFALEN-BLATT (Bielefeld) zur Deutschen Telekom und der »Flatrate« Bielefeld (ots) - Die Telekom tut gut daran, nicht weiter zu klagen. Es ist richtig, dass der Konzern künftig auf die Bezeichnung »Flatrate« verzichtet, wenn dem Kunden die Surfgeschwindigkeit im Internet von einem bestimmten Datenvolumen an gedrosselt wird. Alles andere wäre Verbrauchertäuschung. Neue Tarife, bei denen die Telekom künftig eine Datenbremse einbauen will, müssen anders heißen - auch wenn sich diese Tarife dann schlechter vermarkten lassen. Dies muss aber ebenso für alle anderen Anbieter gelten und auch das Handygeschäft mehr...

  • Neue OZ: Kommentar zu Handel / Karstadt Osnabrück (ots) - Kaufst Du bald bei Karstadt? Das ist mal eine schöne Nachricht: Die schwedische Ikea-Topmanagerin Eva-Lotta Sjöstedt soll den britischen Karstadt-Chef Andrew Jennings ablösen. Der hatte Kunden mit englischen Sprüchen wie "Full of Life" oder "Midseason Sale" verprellt. Stattdessen heißen die Herrensocken bei Karstadt demnächst dann wohl "Bo" und die Bettwäsche "Pelle". Alle Kunden werden geduzt - und Fleischbällchen schmecken doch auch viel besser, wenn sie Köttbullar heißen. Aber im Ernst: Sollte die bisher mehr...

  • First-In-Class Treatment Fycompa® (Perampanel) Launched in Finland for Most Common Form of Epilepsy Hatfield, England (ots/PRNewswire) - Epilepsy treatment Fycompa(R)(perampanel) has today been approved for basic reimbursement in Finland. Perampanel is indicated as an adjunctive treatment for partial onset seizures, with or without secondarily generalised seizures, in people with epilepsy aged 12 years and older.[1] Perampanel is the first and only licensed anti-epileptic drug (AED) to selectively target AMPA receptors, a protein in the brain which plays a critical role in causing seizures.[2] This mechanism of action mehr...

  • Die 114. Canton Fair -- "Aussteller präsentieren Innovationen und Mehrwert im Zeichen des Designs" Guangzhou, China (ots/PRNewswire) - Die 114. Ausgabe der Canton Fair, Chinas wichtigster Messe, ist am 4. November in Guangzhou zu Ende gegangen. Mit nahezu 190.000 Einkäufern aus über 200 Ländern war die Teilnahme im Vergleich zu vorangegangenen Veranstaltungen stabil. Obwohl der Gesamtwert der Exportgeschäfte, die im Rahmen der Messe abgeschlossen wurden, mit 194,61 Milliarden RMB (31,69 Milliarden USD) leicht gesunken war, hatte die Anzahl von mehr...

Mehr zu dem Thema Aktuelle Wirtschaftsnews

Der meistgelesene Artikel zu dem Thema:

DBV löst Berechtigungsscheine von knapp 344 Mio. EUR ein

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Sehr gut